Company Monitoring Page for Daiichi-Sankyo

latest headlines for company on cafepharma

Astellas maintains lead over Daiichi Sankyo with CHMP okay for Xospata
Pharmaforum
Sun, 09/22/19 - 11:02 pm
Tags:
Astellas, AML, Xospata, Europe, Daiichi Sankyo
Astellas' AML drug wins over CHMP — strengthening lead on Daiichi Sankyo
Endpoints
Fri, 09/20/19 - 10:40 pm
Tags:
Astellas, FDA, gilteritinib, Europe, AML, Daiichi Sankyo
Daiichi Sankyo to cut 69 opioid sales jobs
Beckers Hospital Review
Tue, 08/13/19 - 10:26 am
Tags:
Daiichi Sankyo, opioids, layoffs, drug reps
Daiichi Sankyo scores landmark FDA OK for rare tumor drug — albeit with restrictions
Endpoints
Mon, 08/5/19 - 11:32 am
Tags:
Daiichi Sankyo, FDA, pexidartinib, Turalio, tenosynovial giant cell tumors
FDA declines to approve Daiichi Sankyo's blood cancer treatment
Reuters
Fri, 06/21/19 - 11:55 pm
Tags:
Daiichi Sankyo, FDA, quizartinib, acute myeloid leukemia
5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit
Motley Fool
Wed, 06/12/19 - 09:45 am
Tags:
Vertex Pharmaceuticals, VX-445, tezacaftor/ivacaftor, AbbVie, upadacatinib, Daiichi Sankyo, trastuzumab deruxtecan, Celgene, liso-cel, Novartis, LY3298176
Daiichi Sankyo Denies Report That It's Selling Over-the-Counter Drug Unit
BioSpace
Fri, 05/24/19 - 10:40 am
Tags:
Daiichi Sankyo, OTC
Daiichi Sankyo in talks over OTC unit sale – reports
Pharmaforum
Thu, 05/23/19 - 09:56 am
Tags:
Daiichi Sankyo, M&A, OTC
Daiichi Sankyo comes up way short of promised avian flu vaccine production
Fierce Pharma
Wed, 05/22/19 - 08:34 pm
Tags:
Daiichi Sankyo, vaccines, Japan, avian flu, drug shortages
Daiichi Sankyo Takes Two Products to FDA Advisory Panel; Gets One Yes, One No
BioSpace
Wed, 05/15/19 - 11:42 am
Tags:
Daiichi Sankyo, FDA, quizartinib, acute myeloid leukemia, pexidartinib, TGCT
FDA questions credibility of Daiichi data ahead of AdComm
Fierce Biotech
Mon, 05/13/19 - 09:32 am
Tags:
FDA, Daiichi Sankyo, quizartinib, acute myeloid leukemia
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sat, 05/11/19 - 12:31 pm
Tags:
biotech, Achillion, Sesen Bio, The Medicines Company, Amgen, Daiichi Sankyo, earnings
AstraZeneca's share dilution gamble on Daiichi drug pays off
Biopharma Dive
Thu, 05/9/19 - 10:49 am
Tags:
AstraZeneca, Daiichi Sankyo, trastuzumab deruxtecan, metastatic breast cancer
AZ and Daiichi to file new breast cancer drug after trial success
Pharmaforum
Wed, 05/8/19 - 10:05 am
Tags:
AstraZeneca, Daiichi Sankyo, trastuzumab deruxtecan, antibody-drug conjugate
Daiichi picks immuno-oncology bispecific, triggering payout to Zymeworks
Fierce Biotech
Thu, 04/25/19 - 11:45 am
Tags:
Daiichi Sankyo, immuno-oncology, Zymeworks, bispecific antibodies
AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal
Yahoo/Reuters
Fri, 03/29/19 - 10:06 am
Tags:
AstraZeneca, Daiichi Sankyo, breast cancer, trastuzumab deruxtecan
Doubling down on R&D, Daiichi makes executive changes across its U.S. research unit
Fierce Biotech
Fri, 02/22/19 - 11:45 am
Tags:
R&D, Daiichi Sankyo
Daiichi gets speedy FDA review for rare cancer drug
Pharmaforum
Fri, 02/8/19 - 09:38 am
Tags:
Daiichi Sankyo, FDA, pexidartinib, TGCT, priority review
Daiichi Sankyo takes option on diabetes stem cell start-up
Pharmaforum
Sat, 01/12/19 - 11:30 am
Tags:
Daiichi Sankyo, stem cells, Tokyo Institute of Technology, type 1 diabetes, OiDE BetaRevive
Daiichi Sankyo lines up a $900M deal for rights to a cholesterol drug looking to disrupt a blockbuster market
Endpoints
Fri, 01/4/19 - 09:20 am
Tags:
Daiichi Sankyo, Esperion Therapeutics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.